AOCI at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s AOCI?
- Apogee Therapeutics, Inc. (APGE) reported AOCI of -$749K in Q1 2026.
- How has Apogee Therapeutics, Inc.'s AOCI changed year-over-year?
- Apogee Therapeutics, Inc.'s AOCI decreased by 169.7% year-over-year, from $1.07M to -$749K.
- What is the long-term trend for Apogee Therapeutics, Inc.'s AOCI?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s AOCI has grown at a 81.2% compound annual growth rate (CAGR), from $329K to $1.08M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.